Zhengye Biotechnology Holding Ltd (ZYBT) › Cash & EquivalentsZhengye Biotechnology Holding Ltd (ZYBT): Cash & EquivalentsAnnual figures by period end, from SEC filings.18.60M CNYAs of 2024-12-312023-12-31: 15.07M CNY2024-12-31: 18.60M CNY18.60M CNY2023-12-31 Cash & Equivalents (CNY) 2024-12-31Period endedCash & EquivalentsChange YoYSource filing2024-12-3118.60M CNY+23.4%2025-07-03, Balance as of period end2023-12-3115.07M CNYn/a2025-07-03, Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesLong-Term DebtShareholders' EquityOperating Cash FlowCapital ExpendituresFree Cash FlowDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)